首页 > 最新文献

Continence (Amsterdam, Netherlands)最新文献

英文 中文
Efficacy of percutaneous tibial nerve stimulation in pediatric bladder dysfunction: A systematic review and meta-analysis 经皮胫神经刺激治疗小儿膀胱功能障碍的疗效:一项系统回顾和荟萃分析
IF 1.2 Pub Date : 2026-01-21 DOI: 10.1016/j.cont.2026.102316
Rayhan Adji Harimurthi, Fina Widia, Gerhard Reinaldi Situmorang, Harrina Erlianti Rahardjo, Irfan Wahyudi, Arry Rodjani, Putu Angga Risky Raharja

Introduction

Lower urinary tract symptoms (LUTS) impair quality of life in children. Percutaneous tibial nerve stimulation (PTNS), a non-invasive neuromodulation treatment has shown promise in the adult population. However, its efficacy in children has yet to be thoroughly investigated.

Method

A PRISMA-compliant systematic review and meta-analysis was conducted to evaluate the efficacy of percutaneous tibial nerve stimulation (PTNS) in children with neurogenic and non-neurogenic lower urinary tract dysfunction (LUTD). Relevant studies published up to March 2025 were identified through searches of the Cochrane Library, Scopus, PubMed, and Google Scholar databases. Eligible studies included experimental and observational designs that assessed urinary symptoms, urodynamic outcomes, or treatment response in participants aged 18 years or younger. Data extraction was performed independently by two reviewers, and risk of bias was assessed using ROBINS-I for non-randomized studies and ROB 2 for randomized controlled trials. A random-effects model was applied for the meta-analysis.

Results

Twelve studies (including four RCTs) were included. Nine studies reporting lower urinary tract symptoms showed significant reductions in daytime incontinence (RR 0.45; 95 % CI 0.36–0.56; I2 = 68 %), frequency (RR 0.42; 95 % CI 0.30–0.59; I2 = 74 %), urgency (RR 0.39; 95 % CI 0.29–0.53; I2 = 58 %), and nocturnal enuresis (RR 0.39; 95 % CI 0.21–0.73; I2 = 60 %), with an overall pooled RR of 0.43 (95 % CI 0.34–0.55; I2 = 63 %). Five studies reported maximum voided volume (MVV), demonstrating significant increases in within-group analyses (MD 40.36 mL; 95 % CI 17.63–63.10; I2 = 76 %) and between-group comparisons (MD 34.05 mL; 95 % CI 5.53–62.76; I2 = 77 %), for an overall pooled MD of 35.95 mL (95 % CI 21.88–50.03; I2 = 84 %). Other urodynamic variables (Qmax, Qave, PVR, cystometric capacity, Pdetmax, pressure–flow indices) were heterogeneously reported and synthesised narratively; where available, signals favored improved storage function. Subtype effects for MNE vs NMNE were described narratively due to limited, non-uniform reporting.

Conclusion

Tibial nerve stimulation is associated with clinically meaningful improvement in core paediatric LUTS and a pooled increase in MVV, with a favourable safety profile. Benefits appear clearest in non-neurogenic phenotypes, while enuresis shows short-term gains with uncertain durability without maintenance. This review refines the evidence base by pairing symptom effects with urodynamic context and highlights priorities for future trials: ICCS-aligned endpoints, standardized and quantitative urodynamics, phenotype stratification (including MNE vs NMNE), and prospective evaluation of maintenance protocols.
下尿路症状(LUTS)影响儿童的生活质量。经皮胫神经刺激(PTNS),一种非侵入性神经调节治疗已显示出在成人人群的前景。然而,它对儿童的功效尚未得到彻底调查。方法采用符合prisma标准的系统评价和荟萃分析,评价经皮胫神经刺激(PTNS)治疗神经源性和非神经源性下尿路功能障碍(LUTD)患儿的疗效。通过检索Cochrane Library、Scopus、PubMed和谷歌Scholar数据库,确定了截至2025年3月发表的相关研究。符合条件的研究包括实验和观察设计,评估18岁或以下参与者的泌尿系统症状、尿动力学结果或治疗反应。数据提取由两名评论者独立完成,非随机研究采用ROBINS-I评估偏倚风险,随机对照试验采用robins - 2评估偏倚风险。meta分析采用随机效应模型。结果共纳入12项研究(包括4项rct)。9项报告下尿路症状的研究显示,白天尿失禁(RR 0.45; 95% CI 0.36-0.56; I2 = 68%)、尿频(RR 0.42; 95% CI 0.30-0.59; I2 = 74%)、尿急(RR 0.39; 95% CI 0.29-0.53; I2 = 58%)和夜间遗尿(RR 0.39; 95% CI 0.21-0.73; I2 = 60%)的发生率显著降低,总体合并RR为0.43 (95% CI 0.34-0.55; I2 = 63%)。五项研究报告了最大空体积(MVV),显示组内分析(MD 40.36 mL; 95% CI 17.63-63.10; I2 = 76%)和组间比较(MD 34.05 mL; 95% CI 5.53-62.76; I2 = 77%)显著增加,总总MD为35.95 mL (95% CI 21.88-50.03; I2 = 84%)。其他尿动力学变量(Qmax、Qave、PVR、膀胱容量、Pdetmax、压力-流量指数)的报告和综合叙述均不一致;在可能的情况下,信号倾向于改善存储功能。由于有限的、不统一的报道,对跨国公司与非跨国公司的亚型效应进行了叙述。结论胫骨神经刺激与核心儿科LUTS的临床有意义的改善和MVV的综合增加有关,具有良好的安全性。益处在非神经源性表型中表现最明显,而遗尿则显示短期收益,但不确定持久性,无需维持。本综述通过将症状效应与尿动力学背景相结合来完善证据基础,并强调了未来试验的重点:iccs一致的终点,标准化和定量的尿动力学,表型分层(包括MNE与NMNE),以及维持方案的前瞻性评估。
{"title":"Efficacy of percutaneous tibial nerve stimulation in pediatric bladder dysfunction: A systematic review and meta-analysis","authors":"Rayhan Adji Harimurthi,&nbsp;Fina Widia,&nbsp;Gerhard Reinaldi Situmorang,&nbsp;Harrina Erlianti Rahardjo,&nbsp;Irfan Wahyudi,&nbsp;Arry Rodjani,&nbsp;Putu Angga Risky Raharja","doi":"10.1016/j.cont.2026.102316","DOIUrl":"10.1016/j.cont.2026.102316","url":null,"abstract":"<div><h3>Introduction</h3><div>Lower urinary tract symptoms (LUTS) impair quality of life in children. Percutaneous tibial nerve stimulation (PTNS), a non-invasive neuromodulation treatment has shown promise in the adult population. However, its efficacy in children has yet to be thoroughly investigated.</div></div><div><h3>Method</h3><div>A PRISMA-compliant systematic review and meta-analysis was conducted to evaluate the efficacy of percutaneous tibial nerve stimulation (PTNS) in children with neurogenic and non-neurogenic lower urinary tract dysfunction (LUTD). Relevant studies published up to March 2025 were identified through searches of the Cochrane Library, Scopus, PubMed, and Google Scholar databases. Eligible studies included experimental and observational designs that assessed urinary symptoms, urodynamic outcomes, or treatment response in participants aged 18 years or younger. Data extraction was performed independently by two reviewers, and risk of bias was assessed using ROBINS-I for non-randomized studies and ROB 2 for randomized controlled trials. A random-effects model was applied for the meta-analysis.</div></div><div><h3>Results</h3><div>Twelve studies (including four RCTs) were included. Nine studies reporting lower urinary tract symptoms showed significant reductions in daytime incontinence (RR 0.45; 95 % CI 0.36–0.56; I<sup>2</sup> = 68 %), frequency (RR 0.42; 95 % CI 0.30–0.59; I<sup>2</sup> = 74 %), urgency (RR 0.39; 95 % CI 0.29–0.53; I<sup>2</sup> = 58 %), and nocturnal enuresis (RR 0.39; 95 % CI 0.21–0.73; I<sup>2</sup> = 60 %), with an overall pooled RR of 0.43 (95 % CI 0.34–0.55; I<sup>2</sup> = 63 %). Five studies reported maximum voided volume (MVV), demonstrating significant increases in within-group analyses (MD 40.36 mL; 95 % CI 17.63–63.10; I<sup>2</sup> = 76 %) and between-group comparisons (MD 34.05 mL; 95 % CI 5.53–62.76; I<sup>2</sup> = 77 %), for an overall pooled MD of 35.95 mL (95 % CI 21.88–50.03; I<sup>2</sup> = 84 %). Other urodynamic variables (Qmax, Qave, PVR, cystometric capacity, Pdetmax, pressure–flow indices) were heterogeneously reported and synthesised narratively; where available, signals favored improved storage function. Subtype effects for MNE vs NMNE were described narratively due to limited, non-uniform reporting.</div></div><div><h3>Conclusion</h3><div>Tibial nerve stimulation is associated with clinically meaningful improvement in core paediatric LUTS and a pooled increase in MVV, with a favourable safety profile. Benefits appear clearest in non-neurogenic phenotypes, while enuresis shows short-term gains with uncertain durability without maintenance. This review refines the evidence base by pairing symptom effects with urodynamic context and highlights priorities for future trials: ICCS-aligned endpoints, standardized and quantitative urodynamics, phenotype stratification (including MNE vs NMNE), and prospective evaluation of maintenance protocols.</div></div>","PeriodicalId":72702,"journal":{"name":"Continence (Amsterdam, Netherlands)","volume":"17 ","pages":"Article 102316"},"PeriodicalIF":1.2,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146077764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and pilot testing of the ICIQ-S-UDS – A questionnaire for assessing and auditing the patient satisfaction and value of urodynamics ICIQ-S-UDS的开发和试点测试——用于评估和审计患者满意度和尿动力学价值的问卷
IF 1.2 Pub Date : 2026-01-07 DOI: 10.1016/j.cont.2026.102313
Kathryn Jones , Alan Uren , Preksha Kuppanda , Megan Pardoe , Paul Abrams , Hashim Hashim , Laura Thomas , Andrew Gammie , Nikki Cotterill

Background

Urodynamics (UDS) is an investigative procedure used to evaluate bladder symptoms. The International Consultation on Incontinence (ICIQ) Urodynamics-Satisfaction questionnaire, developed in 2004, measured patient satisfaction with UDS.

Aim

To develop new items assessing the perceived ‘value’ of UDS to the patient and to refine and validate the existing questionnaire items on patient ‘satisfaction’.

Methods

New items were developed, and the original questionnaire was updated using a modified Delphi process with clinical experts, followed by refinement through patient cognitive interviews. The resulting developmental questionnaire was pilot tested to assess its measurement properties.

Results

The final 16-item ICIQ-S-UDS, comprising 11 ‘satisfaction’ items, 5 ‘value’ items and two free-text fields, was developed following feedback from an 11-member expert panel and four rounds of cognitive interviews with 12 patients. In the pilot phase, 98 completed the questionnaire and 57 completed the test-retest administration. Internal consistency was α = 0.69 for the ‘satisfaction’ items and α = 0.63 for the ‘value’ items. Exploratory factor analysis was not conducted due to low response variability and borderline Cronbach’s alpha values. Test-retest reliability for most items demonstrated moderate agreement or higher (kappa, κ ≥ 0.41), although 95 % confidence intervals were wide.

Conclusion

The ICIQ-S-UDS can be recommended as a survey tool suitable for auditing and evaluating UDS clinical practice and patient care. However, further evidence from larger and more diverse patient samples are needed to support its use as a robust measurement scale.
背景:尿动力学(UDS)是一种用于评估膀胱症状的调查程序。国际尿失禁咨询(ICIQ)尿动力学满意度问卷于2004年开发,测量了患者对UDS的满意度。目的开发评估UDS对患者感知“价值”的新项目,完善和验证现有的患者满意度问卷项目。方法采用改进的德尔菲法与临床专家对原问卷进行更新,并通过患者认知访谈对原问卷进行细化。由此产生的发展问卷进行了试点测试,以评估其测量特性。结果最终的16项ICIQ-S-UDS,包括11项“满意度”,5项“价值”和2个自由文本字段,是根据11名专家小组成员的反馈和对12名患者的四轮认知访谈制定的。在试点阶段,98人完成了问卷调查,57人完成了复试管理。“满意”项目的内部一致性α = 0.69,“价值”项目的内部一致性α = 0.63。由于反应变异性低,且Cronbach’s alpha值接近临界值,未进行探索性因素分析。大多数项目的重测信度表现出中等或更高的一致性(kappa, κ≥0.41),尽管95%的置信区间很宽。结论ICIQ-S-UDS可作为审计和评价UDS临床实践和患者护理的调查工具。然而,需要来自更大和更多样化的患者样本的进一步证据来支持其作为可靠的测量量表的使用。
{"title":"Development and pilot testing of the ICIQ-S-UDS – A questionnaire for assessing and auditing the patient satisfaction and value of urodynamics","authors":"Kathryn Jones ,&nbsp;Alan Uren ,&nbsp;Preksha Kuppanda ,&nbsp;Megan Pardoe ,&nbsp;Paul Abrams ,&nbsp;Hashim Hashim ,&nbsp;Laura Thomas ,&nbsp;Andrew Gammie ,&nbsp;Nikki Cotterill","doi":"10.1016/j.cont.2026.102313","DOIUrl":"10.1016/j.cont.2026.102313","url":null,"abstract":"<div><h3>Background</h3><div>Urodynamics (UDS) is an investigative procedure used to evaluate bladder symptoms. The International Consultation on Incontinence (ICIQ) Urodynamics-Satisfaction questionnaire, developed in 2004, measured patient satisfaction with UDS.</div></div><div><h3>Aim</h3><div>To develop new items assessing the perceived ‘value’ of UDS to the patient and to refine and validate the existing questionnaire items on patient ‘satisfaction’.</div></div><div><h3>Methods</h3><div>New items were developed, and the original questionnaire was updated using a modified Delphi process with clinical experts, followed by refinement through patient cognitive interviews. The resulting developmental questionnaire was pilot tested to assess its measurement properties.</div></div><div><h3>Results</h3><div>The final 16-item ICIQ-S-UDS, comprising 11 ‘satisfaction’ items, 5 ‘value’ items and two free-text fields, was developed following feedback from an 11-member expert panel and four rounds of cognitive interviews with 12 patients. In the pilot phase, 98 completed the questionnaire and 57 completed the test-retest administration. Internal consistency was α = 0.69 for the ‘satisfaction’ items and α = 0.63 for the ‘value’ items. Exploratory factor analysis was not conducted due to low response variability and borderline Cronbach’s alpha values. Test-retest reliability for most items demonstrated moderate agreement or higher (kappa, κ ≥ 0.41), although 95 % confidence intervals were wide.</div></div><div><h3>Conclusion</h3><div>The ICIQ-S-UDS can be recommended as a survey tool suitable for auditing and evaluating UDS clinical practice and patient care. However, further evidence from larger and more diverse patient samples are needed to support its use as a robust measurement scale.</div></div>","PeriodicalId":72702,"journal":{"name":"Continence (Amsterdam, Netherlands)","volume":"17 ","pages":"Article 102313"},"PeriodicalIF":1.2,"publicationDate":"2026-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145976584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Screening tools to identify a neurogenic cause for pelvic organ dysfunction: A scoping review 筛选工具,以确定盆腔器官功能障碍的神经源性原因:范围审查
IF 1.2 Pub Date : 2025-12-30 DOI: 10.1016/j.cont.2025.102312
Katie Webb , Imogen Pateman , Jason Mallabone , Sophie Prudence , Tabitha Pridham , Jessica Pun , Caroline M. Alexander , Gemma Clunie , Marcus J. Drake

Background

Pelvic organ dysfunction can be an early sign of neurological disease, potentially preceding recognition of the underlying neurogenic mechanism. Screening tools are widely used in healthcare to aid early detection. Many tools exist for assessing pelvic organ symptoms, but it is unclear if any are designed to identify whether neurological disease is causing pelvic organ symptoms, nor whether there may be a potential neurogenic basis for such symptoms in the absence of prior neurological diagnosis.

Objective

To identify assessment and diagnostic tools used to evaluate pelvic organ symptoms in neurological disease and determine their intended purposes, including whether any are designed to evaluate likelihood of neurogenic basis.

Methods

A scoping review was conducted following the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) scoping review guidance. Searches of MEDLINE, CINAHL, and Embase databases included terms such as “assessment and screening tools,” “neurological conditions,” and “pelvic organ dysfunction.”

Results

From 1600 papers screened, 513 were included. Across these, 212 different tools were identified, covering a wide variety of uses. However, none were specifically developed to screen for a neurogenic cause of pelvic organ symptoms in patients with or without a prior neurological diagnosis.

Conclusions

There are currently no tools designed to establish neurogenic mechanisms underlying pelvic organ symptoms. For undiagnosed individuals, this type of tool would trigger prompt neurology review, potentially improving prognosis. Developing a screening tool focused on detecting neurogenic origins could support earlier recognition and management of many neurological conditions associated with pelvic organ dysfunction.
背景盆腔器官功能障碍可能是神经系统疾病的早期征兆,可能早于对潜在神经源性机制的认识。筛查工具广泛用于医疗保健,以帮助早期发现。目前已有许多评估盆腔器官症状的工具,但尚不清楚是否有任何工具旨在确定神经系统疾病是否引起盆腔器官症状,也不清楚在缺乏神经学诊断的情况下,这些症状是否存在潜在的神经源性基础。目的确定用于评估神经系统疾病盆腔器官症状的评估和诊断工具,并确定其预期目的,包括是否设计用于评估神经源性基础的可能性。方法根据系统评价和荟萃分析首选报告项目(PRISMA)范围评价指南进行范围评价。MEDLINE、CINAHL和Embase数据库的搜索包括“评估和筛选工具”、“神经系统状况”和“盆腔器官功能障碍”等术语。结果从1600篇论文中筛选出513篇。通过这些,确定了212种不同的工具,涵盖了各种各样的用途。然而,没有一个是专门开发筛选盆腔器官症状的神经源性原因的患者有或没有先前的神经学诊断。结论目前尚无工具用于建立盆腔器官症状的神经源性机制。对于未确诊的个体,这种类型的工具将触发及时的神经病学检查,潜在地改善预后。开发一种专注于检测神经源性起源的筛选工具可以支持早期识别和管理与盆腔器官功能障碍相关的许多神经系统疾病。
{"title":"Screening tools to identify a neurogenic cause for pelvic organ dysfunction: A scoping review","authors":"Katie Webb ,&nbsp;Imogen Pateman ,&nbsp;Jason Mallabone ,&nbsp;Sophie Prudence ,&nbsp;Tabitha Pridham ,&nbsp;Jessica Pun ,&nbsp;Caroline M. Alexander ,&nbsp;Gemma Clunie ,&nbsp;Marcus J. Drake","doi":"10.1016/j.cont.2025.102312","DOIUrl":"10.1016/j.cont.2025.102312","url":null,"abstract":"<div><h3>Background</h3><div>Pelvic organ dysfunction can be an early sign of neurological disease, potentially preceding recognition of the underlying neurogenic mechanism. Screening tools are widely used in healthcare to aid early detection. Many tools exist for assessing pelvic organ symptoms, but it is unclear if any are designed to identify whether neurological disease is causing pelvic organ symptoms, nor whether there may be a potential neurogenic basis for such symptoms in the absence of prior neurological diagnosis.</div></div><div><h3>Objective</h3><div>To identify assessment and diagnostic tools used to evaluate pelvic organ symptoms in neurological disease and determine their intended purposes, including whether any are designed to evaluate likelihood of neurogenic basis.</div></div><div><h3>Methods</h3><div>A scoping review was conducted following the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) scoping review guidance. Searches of MEDLINE, CINAHL, and Embase databases included terms such as “assessment and screening tools,” “neurological conditions,” and “pelvic organ dysfunction.”</div></div><div><h3>Results</h3><div>From 1600 papers screened, 513 were included. Across these, 212 different tools were identified, covering a wide variety of uses. However, none were specifically developed to screen for a neurogenic cause of pelvic organ symptoms in patients with or without a prior neurological diagnosis.</div></div><div><h3>Conclusions</h3><div>There are currently no tools designed to establish neurogenic mechanisms underlying pelvic organ symptoms. For undiagnosed individuals, this type of tool would trigger prompt neurology review, potentially improving prognosis. Developing a screening tool focused on detecting neurogenic origins could support earlier recognition and management of many neurological conditions associated with pelvic organ dysfunction.</div></div>","PeriodicalId":72702,"journal":{"name":"Continence (Amsterdam, Netherlands)","volume":"17 ","pages":"Article 102312"},"PeriodicalIF":1.2,"publicationDate":"2025-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145976583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intermittent urgency-activated, transcutaneous tibial nerve stimulation: Feasibility and urodynamic effects in overactive bladder 间歇性紧急激活经皮胫神经刺激:膀胱过度活动的可行性和尿动力学效果
IF 1.2 Pub Date : 2025-12-23 DOI: 10.1016/j.cont.2025.102310
Javier A. Muñoz , John PFA. Heesakkers , Diego Leiva , Joaquín O. García , Pablo A. Gálvez
This short report extends our previous proof-of-concept on intermittent, urgency-activated transcutaneous tibial nerve stimulation (TTNS) during invasive cystometry. Twenty-one adults with overactive bladder and detrusor overactivity underwent consecutive baseline and urgency-activated TTNS cystometries, with stimulation manually triggered at each onset of urgency. Compared with baseline, TTNS increased maximum cystometric capacity by 79 mL and reduced maximum detrusor pressure by 26 cmH2O, with marked reductions in involuntary detrusor contractions and urgency urinary incontinence episodes. Overall, 85.7 % of participants met predefined response criteria, including complete suppression of detrusor overactivity in 71.4 % (Criterion A) and partial response in 14.3 % (Criterion B). Exploratory clustering identified three response patterns: a robust global response (capacity and pressure), a moderate balanced response, and a pressure-dominant response with limited capacity change. These findings confirm feasibility but derive from a modest, single-arm physiological study; larger sham-controlled trials are required to validate these patterns and clarify clinical relevance.
这篇简短的报告扩展了我们之前在有创膀胱术中间歇性、紧急激活经皮胫神经刺激(TTNS)的概念验证。21名患有膀胱过度活动和逼尿肌过度活动的成年人接受了连续的基线和紧急激活的TTNS膀胱测量,每次紧急发作时手动触发刺激。与基线相比,TTNS使最大膀胱容量增加了79 mL,最大逼尿肌压力降低了26 cmH2O,非自愿逼尿肌收缩和紧急尿失禁发作明显减少。总体而言,85.7%的参与者符合预定义的反应标准,包括71.4%的人完全抑制逼尿肌过度活动(标准A)和14.3%的人部分反应(标准B)。探索性聚类确定了三种响应模式:稳健的全局响应(容量和压力),适度的平衡响应和有限容量变化的压力主导响应。这些发现证实了可行性,但来自一项适度的单臂生理学研究;需要更大规模的假对照试验来验证这些模式并澄清临床相关性。
{"title":"Intermittent urgency-activated, transcutaneous tibial nerve stimulation: Feasibility and urodynamic effects in overactive bladder","authors":"Javier A. Muñoz ,&nbsp;John PFA. Heesakkers ,&nbsp;Diego Leiva ,&nbsp;Joaquín O. García ,&nbsp;Pablo A. Gálvez","doi":"10.1016/j.cont.2025.102310","DOIUrl":"10.1016/j.cont.2025.102310","url":null,"abstract":"<div><div>This short report extends our previous proof-of-concept on intermittent, urgency-activated transcutaneous tibial nerve stimulation (TTNS) during invasive cystometry. Twenty-one adults with overactive bladder and detrusor overactivity underwent consecutive baseline and urgency-activated TTNS cystometries, with stimulation manually triggered at each onset of urgency. Compared with baseline, TTNS increased maximum cystometric capacity by 79 mL and reduced maximum detrusor pressure by 26 cmH<sub>2</sub>O, with marked reductions in involuntary detrusor contractions and urgency urinary incontinence episodes. Overall, 85.7 % of participants met predefined response criteria, including complete suppression of detrusor overactivity in 71.4 % (Criterion A) and partial response in 14.3 % (Criterion B). Exploratory clustering identified three response patterns: a robust global response (capacity and pressure), a moderate balanced response, and a pressure-dominant response with limited capacity change. These findings confirm feasibility but derive from a modest, single-arm physiological study; larger sham-controlled trials are required to validate these patterns and clarify clinical relevance.</div></div>","PeriodicalId":72702,"journal":{"name":"Continence (Amsterdam, Netherlands)","volume":"17 ","pages":"Article 102310"},"PeriodicalIF":1.2,"publicationDate":"2025-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145925648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The bladder trigone: A sensory organ? 膀胱三角区:感觉器官?
IF 1.2 Pub Date : 2025-12-19 DOI: 10.1016/j.cont.2025.102309
Karl-Erik Andersson , Anthony Kanai , Bengt Uvelius
The bladder trigone is a distinct anatomical and functional subregion of the urinary bladder, defined by its triangular configuration between the ureteral orifices and the internal urethral orifice. Although traditionally less studied compared to the bladder dome and detrusor body, recent morphological, molecular, and transcriptomic analyses reveal that the trigone is highly specialized. Understanding the trigone's role in sensory signaling, urinary continence, and pathophysiological conditions such as bladder pain syndrome and vesicoureteral reflux provides a basis for developing therapeutic approaches to treat disorders involving this structure.
膀胱三角区是膀胱的一个独特的解剖和功能亚区,由输尿管口和内尿道口之间的三角形结构定义。尽管与膀胱穹窿和逼尿肌体相比,传统上研究较少,但最近的形态学、分子和转录组学分析表明三角区是高度特化的。了解三角区在感觉信号传导、尿失禁和病理生理状况(如膀胱疼痛综合征和膀胱输尿管反流)中的作用,为开发治疗涉及该结构的疾病的治疗方法提供了基础。
{"title":"The bladder trigone: A sensory organ?","authors":"Karl-Erik Andersson ,&nbsp;Anthony Kanai ,&nbsp;Bengt Uvelius","doi":"10.1016/j.cont.2025.102309","DOIUrl":"10.1016/j.cont.2025.102309","url":null,"abstract":"<div><div>The bladder trigone is a distinct anatomical and functional subregion of the urinary bladder, defined by its triangular configuration between the ureteral orifices and the internal urethral orifice. Although traditionally less studied compared to the bladder dome and detrusor body, recent morphological, molecular, and transcriptomic analyses reveal that the trigone is highly specialized. Understanding the trigone's role in sensory signaling, urinary continence, and pathophysiological conditions such as bladder pain syndrome and vesicoureteral reflux provides a basis for developing therapeutic approaches to treat disorders involving this structure.</div></div>","PeriodicalId":72702,"journal":{"name":"Continence (Amsterdam, Netherlands)","volume":"17 ","pages":"Article 102309"},"PeriodicalIF":1.2,"publicationDate":"2025-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146022895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictive factors of clinical success for treatment of urgency urinary incontinence using implantable tibial neuromodulation 植入式胫骨神经调节治疗急迫性尿失禁临床成功的预测因素
IF 1.2 Pub Date : 2025-12-18 DOI: 10.1016/j.cont.2025.102308
Harry J. Kendall , Roger R. Dmochowski , John P.F.A. Heesakkers

Introduction

Implantable tibial Neuromodulation (iTNM) is an emerging therapy for overactive bladder (OAB). In the Revi® system (BlueWind Medical), the implanted electrode is activated through an external wearable. This study aims to identify characteristics tied to a positive clinical response.

Methods

The OASIS Study was a prospective, multicentre, single arm trial, evaluating Revi in adult females with urgency urinary incontinence. Baseline characteristics and voiding diaries at 1, 3, 6, 9, and 12months were analyzed. Multivariate logistic regression identified predictors of response, with significance set at p < 0.05.

Results

A total of 151 participants were implanted, with 135–146 providing voiding diaries throughout 12 months of follow-up. The overall success rate at 12 months was 82 %. Prior use of OAB medication was a positive predictor of success at 6, 9 and 12 months (OR; 3.31, 5.14, 4.51, respectively). Larger leg circumference (>23 cm) predicted lower odds of success at 3 months (OR 0.16) and 6 months (OR 0.28). BMI >30 kg/m2 was negatively associated with success at 9- and 12-months (OR 0.30 and OR 0.29, respectively). Presence of large leaks reduced odds of success at all timepoints, except for 12 months (OR range 0.15–0.5). Baseline quality of life was associated with success, though not linearly.

Conclusion

Most female participants benefited from the Revi System treatment. Larger leg circumference and higher BMI predicted lower success at early and later timepoints, respectively. Large leaks were modestly associated with poorer outcomes. Recent OAB medication use predicted better treatment response.
植入式胫骨神经调节(iTNM)是一种治疗膀胱过度活动症(OAB)的新方法。在Revi®系统(BlueWind Medical)中,植入电极通过外部可穿戴设备激活。本研究旨在确定与积极临床反应相关的特征。OASIS研究是一项前瞻性、多中心、单臂试验,评估Revi对成年女性急迫性尿失禁的治疗效果。分析1、3、6、9和12个月的基线特征和排尿日记。多因素逻辑回归确定了反应的预测因素,显著性设置为p <; 0.05。结果共植入151例,其中135 ~ 146例在12个月的随访中提供排尿日记。12个月的总成功率为82%。既往使用OAB药物是6、9和12个月成功的积极预测因子(OR分别为3.31、5.14、4.51)。较大的腿围(23厘米)在3个月(OR 0.16)和6个月(OR 0.28)时预测较低的成功几率。BMI >;30 kg/m2与第9个月和第12个月的成功呈负相关(OR分别为0.30和0.29)。除了12个月(OR范围0.15-0.5)外,大泄漏的存在降低了所有时间点的成功几率。基线生活质量与成功相关,尽管不是线性的。结论Revi系统治疗对大多数女性患者都有好处。较大的腿围和较高的BMI分别预示着较低的早期和后期的成功率。较大的泄漏与较差的结果有一定的关联。最近使用OAB药物预测更好的治疗反应。
{"title":"Predictive factors of clinical success for treatment of urgency urinary incontinence using implantable tibial neuromodulation","authors":"Harry J. Kendall ,&nbsp;Roger R. Dmochowski ,&nbsp;John P.F.A. Heesakkers","doi":"10.1016/j.cont.2025.102308","DOIUrl":"10.1016/j.cont.2025.102308","url":null,"abstract":"<div><h3>Introduction</h3><div>Implantable tibial Neuromodulation (iTNM) is an emerging therapy for overactive bladder (OAB). In the Revi® system (BlueWind Medical), the implanted electrode is activated through an external wearable. This study aims to identify characteristics tied to a positive clinical response.</div></div><div><h3>Methods</h3><div>The OASIS Study was a prospective, multicentre, single arm trial, evaluating Revi in adult females with urgency urinary incontinence. Baseline characteristics and voiding diaries at 1, 3, 6, 9, and 12months were analyzed. Multivariate logistic regression identified predictors of response, with significance set at p &lt; 0.05.</div></div><div><h3>Results</h3><div>A total of 151 participants were implanted, with 135–146 providing voiding diaries throughout 12 months of follow-up. The overall success rate at 12 months was 82 %. Prior use of OAB medication was a positive predictor of success at 6, 9 and 12 months (OR; 3.31, 5.14, 4.51, respectively). Larger leg circumference (&gt;23 cm) predicted lower odds of success at 3 months (OR 0.16) and 6 months (OR 0.28). BMI &gt;30 kg/m<sup>2</sup> was negatively associated with success at 9- and 12-months (OR 0.30 and OR 0.29, respectively). Presence of large leaks reduced odds of success at all timepoints, except for 12 months (OR range 0.15–0.5). Baseline quality of life was associated with success, though not linearly.</div></div><div><h3>Conclusion</h3><div>Most female participants benefited from the Revi System treatment. Larger leg circumference and higher BMI predicted lower success at early and later timepoints, respectively. Large leaks were modestly associated with poorer outcomes. Recent OAB medication use predicted better treatment response.</div></div>","PeriodicalId":72702,"journal":{"name":"Continence (Amsterdam, Netherlands)","volume":"17 ","pages":"Article 102308"},"PeriodicalIF":1.2,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145925578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial Comment: LUTD in rare pediatric neurological conditions: A joint report by the neurourology promotion committee and children and young adults committee 编辑评论:LUTD在罕见的儿科神经系统疾病:由神经病学促进委员会和儿童和青少年委员会的联合报告
IF 1.2 Pub Date : 2025-12-01 DOI: 10.1016/j.cont.2025.102301
Cagri Akin Sekerci , Selcuk Yucel , Tufan Tarcan
{"title":"Editorial Comment: LUTD in rare pediatric neurological conditions: A joint report by the neurourology promotion committee and children and young adults committee","authors":"Cagri Akin Sekerci ,&nbsp;Selcuk Yucel ,&nbsp;Tufan Tarcan","doi":"10.1016/j.cont.2025.102301","DOIUrl":"10.1016/j.cont.2025.102301","url":null,"abstract":"","PeriodicalId":72702,"journal":{"name":"Continence (Amsterdam, Netherlands)","volume":"16 ","pages":"Article 102301"},"PeriodicalIF":1.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145617674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Urinary and fecal incontinence following childbirth 分娩后尿和大便失禁
IF 1.2 Pub Date : 2025-11-25 DOI: 10.1016/j.cont.2025.102306
Ian Milsom, Maria Gyhagen
{"title":"Urinary and fecal incontinence following childbirth","authors":"Ian Milsom,&nbsp;Maria Gyhagen","doi":"10.1016/j.cont.2025.102306","DOIUrl":"10.1016/j.cont.2025.102306","url":null,"abstract":"","PeriodicalId":72702,"journal":{"name":"Continence (Amsterdam, Netherlands)","volume":"17 ","pages":"Article 102306"},"PeriodicalIF":1.2,"publicationDate":"2025-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145738227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A mixed-methods scoping review on bladder self-care practices in women with and without lower urinary tract symptoms 对有或无下尿路症状的妇女膀胱自我保健实践的混合方法范围审查
IF 1.2 Pub Date : 2025-11-24 DOI: 10.1016/j.cont.2025.102300
Jean F. Wyman , Kristine M.C. Talley , Melanie Meister , Diane K. Newman , Amy M. Claussen , Julia Geynisman-Tan , Deepa Camega , Jeni Hebert-Beirne , Lisa Kane Low , Ann Stapleton
This scoping review synthesized literature on women's bladder self-care practices by: 1) describing study characteristics; 2) identifying questionnaires used to assess self-care; and 3) summarizing behaviors relevant to bladder health. Five databases and reference lists were searched through April 2025 for qualitative, quantitative, and mixed-methods studies. Ninety-seven studies were included, identifying 107 behaviors grouped into four domains: Toileting and Bladder Management, Personal Care and Hygiene Practices, Lifestyle and Behavioral Strategies, and Therapeutic Interventions. Most studies focused on women with urinary symptoms, with few population-based samples. No comprehensive, validated questionnaire assessing the full scope of bladder self-care was identified. Women engage in diverse behaviors that may influence bladder health. A validated, multidimensional questionnaire is needed to assess these behaviors, identify risk and protective factors, and guide preventive interventions.
本综述综合了有关女性膀胱自我护理实践的文献:1)描述研究特点;2)确定自我保健评估问卷;3)总结与膀胱健康相关的行为。到2025年4月,对5个数据库和参考文献进行了定性、定量和混合方法研究的检索。纳入了97项研究,确定了107种行为,分为四个领域:如厕和膀胱管理,个人护理和卫生习惯,生活方式和行为策略,以及治疗干预。大多数研究集中在有泌尿系统症状的女性身上,很少有基于人群的样本。没有一个全面的、有效的问卷来评估膀胱自我护理的全部范围。女性从事各种可能影响膀胱健康的行为。需要一份有效的多维问卷来评估这些行为,确定风险和保护因素,并指导预防干预措施。
{"title":"A mixed-methods scoping review on bladder self-care practices in women with and without lower urinary tract symptoms","authors":"Jean F. Wyman ,&nbsp;Kristine M.C. Talley ,&nbsp;Melanie Meister ,&nbsp;Diane K. Newman ,&nbsp;Amy M. Claussen ,&nbsp;Julia Geynisman-Tan ,&nbsp;Deepa Camega ,&nbsp;Jeni Hebert-Beirne ,&nbsp;Lisa Kane Low ,&nbsp;Ann Stapleton","doi":"10.1016/j.cont.2025.102300","DOIUrl":"10.1016/j.cont.2025.102300","url":null,"abstract":"<div><div>This scoping review synthesized literature on women's bladder self-care practices by: 1) describing study characteristics; 2) identifying questionnaires used to assess self-care; and 3) summarizing behaviors relevant to bladder health. Five databases and reference lists were searched through April 2025 for qualitative, quantitative, and mixed-methods studies. Ninety-seven studies were included, identifying 107 behaviors grouped into four domains: Toileting and Bladder Management, Personal Care and Hygiene Practices, Lifestyle and Behavioral Strategies, and Therapeutic Interventions. Most studies focused on women with urinary symptoms, with few population-based samples. No comprehensive, validated questionnaire assessing the full scope of bladder self-care was identified. Women engage in diverse behaviors that may influence bladder health. A validated, multidimensional questionnaire is needed to assess these behaviors, identify risk and protective factors, and guide preventive interventions.</div></div>","PeriodicalId":72702,"journal":{"name":"Continence (Amsterdam, Netherlands)","volume":"17 ","pages":"Article 102300"},"PeriodicalIF":1.2,"publicationDate":"2025-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145738229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancing access to incontinence products in Low- and middle-income countries 加强在低收入和中等收入国家获得失禁产品
IF 1.2 Pub Date : 2025-11-19 DOI: 10.1016/j.cont.2025.102305
Muhidin Adan Abdulla
{"title":"Enhancing access to incontinence products in Low- and middle-income countries","authors":"Muhidin Adan Abdulla","doi":"10.1016/j.cont.2025.102305","DOIUrl":"10.1016/j.cont.2025.102305","url":null,"abstract":"","PeriodicalId":72702,"journal":{"name":"Continence (Amsterdam, Netherlands)","volume":"17 ","pages":"Article 102305"},"PeriodicalIF":1.2,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145651811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Continence (Amsterdam, Netherlands)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1